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Abstract
Objective: To assess the frequency of dietary xenoglycanNeu5Gc and antibodies in males and females and its impact on fertility.  
Design: Prospective study of semen, uterine lavage, and follicular fluid from subjects undergoing infertility evaluation or in vitro fertilization (IVF) and fertile controls. 
Setting:  University based infertility program. 
Participants: Males (n=23) and females (n=27) undergoing semen analysis and saline infusion sonography as part of their diagnostic evaluation and 37 women 
undergoing IVF were compared to fertile male (n=15) and female (n=14) controls.
Intervention: Neu5Gc was measured by affinity purified antibody staining on Western blots, flow cytometry, and by high performance liquid chromatography.  Anti-
Neu5Gc antibodies were determined by ELISA. 
Main parameters measured:  Frequency and levels of Neu5Gc antigen within sperm and endometrial cells and antibodies in semen, uterine lavage, and follicular fluid. 
Semen quality and IVF outcomes were assessed between antigen and antibody positive and negative subjects.
Results: In infertile subjects,Neu5Gc was detected in 26% of sperm and 54% of endometrial cells compared to 0% in male and 0% female controls. Anti-Neu5Gc 
antibodies were identified in 54% of seminal fluid, 41% in uterine lavage and 43% of follicular fluid samples.  There were no differences in semen parameters, oocyte 
quality, and embryo development in the presence or absence of Neu5Gc antigen or antibody. However, clinical pregnancy rate was significantly lower in the presence 
of anti-Neu5Gc antibodies intrauterine lavage (0% vs. 54.5.0%, p<0.05).
Conclusions: Neu5Gc and directed antibodies are present in reproductive tracts of both male and female infertility subjects.  Our results suggest their presence may 
interfere with fertility within the uterine environment.
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Introduction
All cell surfaces are coated by a complex array of glycans.  In 
mammals, the majority of these surface glycans are capped with sialic 
acids, nine carbon backbone acidic amino sugars.  By virtue of their 
position and high abundance at the outermost cell surface, sialic acids 
are involved in multiple functions including cellular recognition 
during development, infection and immune processes [1]. The role of 
sialic acids in reproduction is not fully understood, but acquisition of a 
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sialylated glycocalyx is crucial to sperm function [2].  Most recently, it 
has been shown that sperm sialidases are involved in desialylation during 
capacitation [3] and that sialic acids of sialyl Lewis X glycans on human 
egg zona pelucida are essential for sperm binding [4]. Implantation also 
involves L-selectins on the blastocyst known to interact with sialic acid 
containing ligands on the endometrium [5,6]. The two most common 
sialic acids in mammals are N-glycolylneuraminic acid (Neu5Gc) 
and N-acetylneuraminic acid (Neu5Ac) [1].  Most mammals have an 
abundance of each molecule in different ratios on various cell surfaces. 
In contrast, humans have lost the ability to convert Neu5Ac to Neu5Gc 
due to a loss-of-function mutation in the cytidine monophosphate N–
acetylneuraminic acid hydroxylase(CMAH)gene encoding the CMAH 
enzyme [7].  As a result, humans lack glycans capped by endogenous 
Neu5Gc on their cell surfaces and have an excess of Neu5Ac [8], a 
difference in hundreds of millions of molecules per cell. Despite the 
inability to endogenously produce Neu5Gc, dietary intake of red 
meat and dairy products, the richest sources of Neu5Gc, can result in 
accumulation and incorporation of trace amounts of Neu5Gc into the 
glycocalyx on human cells [9]. This has been reported in both human 
tumors such as breast, colon, and skin cancers [10] and normal tissues 
including secretory epithelium and blood vessels [9]. Moreover, most 
humans have circulating anti-Neu5Gc antibodies [9,11] targeting this 
xenoglycan in serum [9,12]. Levels of anti-Neu5Gc antibodies vary 
among different individuals, but it has been suggested that chronic 
exposure to Neu5Gc and incorporation of this xenoglycan combined 
with circulating anti-Neu5Gc antibodies can promote chronic 
inflammatory states contributing to various diseases [14] including 
some of the diseases associated Hanganutziu-Deicher antibodies, which 
are reactive against Neu5Gc [13,14]. There is also experimental evidence 
for Neu5Gc acting as a xeno-auto antigen capable of exacerbating an 
inflammatory reaction within vasculature endothelium [15]. A recent 
study proved that the dietary xenoglycan Neu5Gc causes increased 
cancer via systemic inflammation in a mouse model [16]. More 
sensitive detection methods have provided evidence for widespread 
anti-Neu5Gc antibodies in most humans tested, including IgM, IgA, 
and IgG antibodies [17].  There is mounting evidence that the dietary 
bioaccumulation of xenoglycan and production of targeting antibodies 
might underlie various forms of xenosialitis [18]. 
We are unaware of any information on the presence of the 
xenoglycan Neu5Gc and anti-Neu5Gc antibodies in the human 
reproductive tract or of their potential consequences on fertility. 
The female reproductive tract through which sperm must traverse 
and in which embryos must implant contains antibodies originating 
from plasma (IgG) and locally produced (IgA) antibodies [19]. 
Inflammation and the resulting abnormal milieu is a possible 
mechanism for impaired implantation as seen in certain disease states 
(i.e. endometriosis, auto-immune diseases, tubal infertility) [20,21].  It 
has recently been suggested, that the loss of Neu5Gc may have caused 
reproductive incompatibility in ancestral hominin populations due to 
sexual selection by female immunity against the xenoglycan Neu5Gc 
on sperm or implanting blastocysts [22].  In a murine model, Cmah 
null females with antibodies against Neu5Gc have reduced fertility 
when mated with Neu5Gc positive wild-type males implicating that 
female immunity can result in reproductive incompatibility [22]. 
Thus, our objectives were 1) to determine if Neu5Gc antigen and 
targeting antibodies are present within the human reproductive tracts 
of males  and females; 2) to compare levels between patients seeking 
infertility evaluation and fertile controls; 3) to assess whether antigen or 
antibody presence in the reproductive tract had any impact on semen 
quality and in-vitro fertilzation (IVF) outcomes, and 4) to investigate 
if they were associated with dietary intake of foods containing the 
antigenic Neu5Gc xenoglycan.   
Materials and methods
This study was reviewed and approved by the Christ Hospital 
Institutional Review Board (Cincinnati, OH) and the study was in 
compliance with privacy-act guidelines.
Patient population
From July 2010 to August 2014, subjects were recruited to participate 
in this prospective clinical study. Subjects enrolled were 1) those 
undergoing diagnostic infertility testing including a semen analysis 
(n=23) and saline infusion sonography (n=27); 2) patients undergoing 
in vitro fertilization (IVF) cycles (n=37, 20 of which underwent a 
uterine lavage after a saline infusion sonography) and 3) fertile male 
Figure 1. Dietary Questionnaire.
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(n=15) and female oocyte donors (n=14). Written informed consent 
was obtained from each subject candidate.  Men between the ages of 
18–50 years without previous vasectomy were eligible to participate.  
Subjects meeting inclusion criteria were given a dietary 
questionnaire specifically designed for this study (Figure 1) including 
frequency of meat, dairy, and protein supplement intake as well as 
formula use as an infant, all of which contain the xenoglycan Neu5Gc. 
Xenoglycan load based on the questionnaire were calculated by using 
values from Tangvoranuntakul et al. [9].
Sample acquisition 
Seminal fluid and sperm samples: Semen was collected on site in a 
sterile plastic specimen cup after a recommended period of abstinence 
of 2-5 days.  The specimens were allowed to liquefy at 37°C for 30 
minutes and analyzed within one hour of collection time for semen 
quality parameters and motion characteristics.  Semen samples were 
then centrifuged twice for 8 minutes each time at 300 x g (1200 RPM), 
and the supernatant (seminal fluid) was isolated and frozen at -20°C 
before sample analysis.  The remaining sperm pellet was reconstituted 
with 1-2 mL of phosphate buffered saline (PBS), then frozen at -20°C 
for later analysis.
Uterine samples: Saline infusion sonography was performed 
either during the follicular phase of a spontaneous menstrual cycle 
or following a progestin withdrawal bleed. Following speculum 
examination and cervical cleansing, a 2 lumen 5 French balloon catheter 
(Cooper Surgical Inc. Trumbull, CT) flushed with sterile saline was 
placed into the lower uterine segment followed by instillation of sterile 
saline through the catheter until an adequate evaluation of the uterine 
cavity was obtained. At completion of the saline infusion sonography, 
fluid was aspirated collecting both endometrial cells and saline (mean 
volume ~ 2 ml) for uterine lavage specimens.   Uterine specimen 
samples were then centrifuged 15 minutes at 300 x g (1200 RPM), and 
the supernatant was isolated from the remaining pellet (endometrial 
cells). Both samples were frozen at -20°C until sample analysis.
Assisted reproduction
Ovarian stimulation-oocyte retrieval: Prior to ovulation induction 
for IVF, all female partners had normal uterine cavities as demonstrated 
on saline infusion sonography and operative hysteroscopy to correct 
cavity pathology. 
Subjects undergoing IVF used a GnRH antagonist protocol. 
Briefly, ovarian stimulation was started on cycle day 3 following an 
oral contraceptive pill withdrawal bleed using daily injections of 150 to 
300 IU of recombinant follicle stimulating hormone (rFSH) [Follistim 
AQ Cartridge; Merck & Co., Inc., Whitehouse Station, NJ, USA].  All 
cycles were monitored by serum estradiol levels and transvaginal 
ultrasound and the dose was adjusted according to response. GnRH-
antagonist (Ganirelix, 0.25 mg, subcutaneously daily [Merck & Co., 
Inc., Whitehouse Station, NJ, USA]) was begun when lead follicles were 
12-14 mm. When ≥3 follicles reached 18-20 mm, urinary hCG 10,000 
IU was given and was followed by transvaginal oocyte aspiration 36 
hours later. 
Follicular fluid and serum samples: Follicular fluid from the first 
dominant follicle was collected for evaluation. Follicular fluid samples 
were centrifuged similar to uterine lavage specimens.  Granulosa cells 
were discarded and follicular fluid was stored at -20°C.  Serum was 
collected around the time of hCG administration, and samples were 
centrifuged (same as uterine lavage), red blood cells discarded, and 
serum was similarly stored at -20°C until processing.
IVF-ICSI-embryo quality grading, culture, and embryo transfer: 
Fertilization was performed on the day of retrieval with sperm from a 
partner or donor using conventional IVF or intracytoplasmic sperm 
injection (ICSI). Three to four hours after oocyte retrieval, fertilization 
was performed in IVC-1 media by either conventional insemination 
or by ICSI in the presence of male factor infertility.  The following 
day, fertilization was confirmed by the presence of two pronuclei. All 
normally fertilized embryos were cultured sequentially in Vitrolife’s 
G1.3 and G2.3 media, supplemented with 5% protein.    An embryo 
transfer was performed either three or five days after oocyte retrieval 
under ultrasound guidance.  At least 4 good quality cleavage stage 
embryos were required to continue culture to the blastocyst stage.  Day-
3 embryos were evaluated according to cell number and were graded 
according to blastomere uniformity and the degree of fragmentation. 
Day-3 embryo quality was ranked as good if >6 cells, grade 2 (slight to 
moderately uneven cells and slight to moderate fragmentation). Two to 
three embryos with the highest cell number and best morphology were 
selected for embryo transfer.  Surplus embryos were then transferred 
to IVC-3 blastocyst media, which were re-evaluated on days 5 and/or 
6 for development into suitable blastocysts for cryopreservation [23].   
Pregnancy confirmation: Pregnancy was confirmed by serial 
serum β-hCG levels 7 to 10 days following embryo transfer.  Clinical 
pregnancies were confirmed with transvaginal ultrasonography by 
a gestational sac at 6 to 7 weeks. Hormonal supplementation was 
continued until 10 weeks gestation or until a negative serum β-hCG.
Neu5Gc antigen detection: Neu5Gc was detected using an affinity 
purified polyclonal IgY antibody raised in chickens[24]. Frozen sperm 
were thawed and washed 3X with PBS. For flow cytometry, thawed 
sperm were first blocked with 0.5% fish gelatin in PBS (PBSfg) for 
30 min at RT, then incubated with anti-Neu5Gc IgY at 1:1000 in 
PBSfg for 30 min on ice, washed 3 times with PBSfg, incubated with 
secondary donkey-anti chicken Dy488 at 1:1000 in PBSfg for 30 
min on ice, washed 3X with PBSfg and measured on a FACScalibur 
Flow cytometer. Controls included: mild periodate treatment (2mM 
NaIO4), which truncates the side chain of sialic acid and confirms 
sialic acid dependence of Ab staining; inhibition of the Ab with 10 nM 
polyNeu5Gc, and non-specific isotype control. 
Human sperm Neu5GC detection via Western Blot
Frozen sperm samples from control fertile males were thawed and 
centrifuged (500 g, 5 minutes). The supernatant, containing seminal 
fluid, was aspirated, followed by two washing cycles characterized by 
addition of 1 mL of phosphate buffered saline (PBS), centrifugation 
(500 g, 5 minutes), and aspiration of the supernatant. The remaining 
pellet was resuspended in 100 uL of PBS. Protein concentration was 
determined by BCA, then an equal amount of protein (18 or 30 ug per 
lane) was loaded on a 1.5 mm 7% SDS-PAGE gel and run until the dye 
front almost ran off the gel (20 minutes at 20 mAmps per gel, 60-80 
minutes at  40  mAmps per gel). Gels were washed with milliQ water, 
then transferred onto a polyvinyldene fluoride (PVDF) membrane 
using a Bio-Rad SemiDry Transfer Cell for 1 hour (100 mAmps per 
membrane). Membranes were washed (5 minutes) in PBS-T (0.1% 
Tween), blocked for one hour at room temperature in 0.5% fish gelatin 
PBS-T. Membranes were then incubated in PBS-T with 1:10,000 anti-
Neu5GC chicken IgY overnight at 4°C. Membranes were washed four 
times (7 minutes in PBS-T), followed by a secondary incubation in 
PBS-T with 1:10,000 LiCOR donkey a-chicken 800 antibody for 45 
minutes at room temperature. Membranes were washed four more 
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times (7 minutes in PBS-T) before being imaged on a LiCOR Imaging 
System.
For western blots, thawed sperm membrane proteins were 
extracted with lysis buffer and loaded on denaturing SDS PAGE. The 
gels were transferred to membranes and blocked with PBSfg overnight 
at 4°C. Blots were incubated in 1:50,000 affinity purified chicken IgY in 
TBST, 0.5% fish gelatin (Sigma) and 2 mg/ml of purified bovine serum 
albumin (BSA). Blots were washed and incubated with secondary 
HRP-conjugated donkey anti-chicken Ab for 1 h at RT. Blots were 
developed using luminescent substrate (Pierce, Thermo Fisher 
Scientific, Rockford IL). 
Shed endometrial cells were harvested from the pellet of the 
centrifuged thawed uterine flush samples. The cells were washed 3X 
with ddH2O and then incubated in 2M acetic acid for total sialic acid 
release.  Released sialic acids were analyzed by high performance liquid 
chromatography (HPLC) of 1,2-diamino-4,5-methylenedeoxybenzene 
(DMB)  derivatizedsialic acid extracts obtained from shed epithelial 
cells after 2 M acetic acid hydrolysis at 80°C for 3 hrs. Released sialic 
acids were filtered through microcon 10 columns, MW 10 KD (Amicon 
Millipore, Billerica, MA) by centrifuging at 13,000  g for 20 min, 
treated with mild base and derivatized in DMB for 2.5 h at 50°C in 
the dark prior to HPLC analysis. HPLC was performed over Varian 
C18 reverse phase column, under isocratic conditions in 83% water, 
7% methanol and 8% acetonitrile at a flow rate of 0.9 ml/min over 50 
min on a Hitachi HPLC [25,26]. sialic acid standards were from bovine 
submaxillarymucin as well as commercially available Neu5Ac (Nacalai, 
San Diego, CA) and Neu5Gc (Inalco, San Luis Obispo, CA).
Anti-Neu5Gc antibody detection
Antibody titers in seminal fluid, uterine lavage, follicular fluid, 
and serum were determined by ELISA using Neu5Gc- and Neu5Ac-
polyacrylamide beads as plated targets (Padler-Karavani et al., 
2008). Sialic acid dependence of antibody binding was confirmed by 
mild periodate treatment to destroy the side chain of sialic acidsand 
controlled for by mock treatment without the premixed periodate and 
sodium borohydride quenching agent. 
Additional control samples were tested for anti-Neu5Gc antibodies 
by plating pooled WT mouse sera free of any anti human IgG and 
IgA. Human IgG or IgA were coated at various concentrations for 
standards (Padler-Karavani et al., 2013).  All samples were diluted in 
1XPBS/ chicken albumin/ pooled CMAH ko mouse sera (free of anti-
humanIgG and IgA). All samples were diluted 100 fold, except for 
uterine samples which were diluted 10 fold. The secondary antibody 
used was AP goat anti human IgG or or AP goat anti human IgA.
Clinical outcomes in fertility patients  
Outcomes measured included 1) The frequency of Neu5Gc Antigen 
in semen samples and EC and Neu5GC antibody in seminal fluid, 
uterine lavage and follicular fluid; 2) The effect of Neu5GC antigen 
or anti- Neu5GC antibodies on semen parameters (semen quality 
including volume, concentration, motility, and strict morphology) and 
IVF outcomes (i.e. number of retrieved oocytes, fertilized embryos, 
embryo quality, rates of blastulation, pregnancy rate (PR) and clinical 
pregnancy rate (CPR).  Analyses were also performed to correlate 
Neu5GC antigen or anti- Neu5GC antibody presence in reproductive 
tissue with dietary intake.
Statistics
Statistical analyses were performed using the Statistical Package 
for the Social Sciences (SPSS version 18; SPSS, Inc., Chicago, IL). 
Student’s t-test was utilized to compare means for parametric data 
between Neu5Gc Ag and Ab positive and negative subjects.  Chi-square 
was used for categorical comparisons.  Pearson correlation was used 
for correlation analysis. Significance was assessed at p<0.05. Means 
expressed as ±SEM.
Results
Detection of Neu5Gc Antigen and Anti-Neu5Gc Antibodies
Semen and sperm samples: Neu5Gc was identified in 26% 
(6/23) of sperm samples from males undergoing fertility evaluation 
compared to 0/15 male controls, p<0.05. Anti-Neu5Gc antibodies 
in males undergoing fertility evaluation were detected in 54% of SF 
(8/13; insufficient sample in 10 patients). Specifically, 54% had IgA Abs 
detected, 38% had IgG and 38% IgM, respectively. Antibodies were not 
measured in fertile male controls. (Figure 2 and Table 1).
Uterine lavage, follicular fluid, and serum: The presence of 
Neu5Gc in endometrial cells from female infertility patients was 
detected in 54% (9/17; insufficient sample in 10 patients). Neu5Gc 
was not measured in fertile female controls. Anti-Neu5Gc antibodies 
were detected in 41% of uterine lavage (11/27) from female infertility 
patients (specifically, 37% IgA, 27% IgG, and 0% IgM) compared to 
none of the female controls (0%, 0/14, p<0.05) Anti-Neu5Gc antibodies 
were detected in 43% of follicular fluid (16/37), and 44% of serum 
([14/32]; insufficient sample in 5 patients) (Table 2). Of the follicular 
fluid samples, 22% had IgA, 32% IgG, and 19% IgM while in serum 
samples, 33% had IgA, 60% IgG, and 0% IgM, respectively. Neu-5Gc 
antibodies in follicular fluid and serum were not measured in fertile 
Figure 2. ELISA for Anti-Neu5Gc antibodies, flow cytometry and fluorescent 
microphotograph of sperm.
A) ELISA data for anti-Neu5Gc antibodies in seminal fluid from infertility patients. B) 
Flow cytometry on sperm cells from infertility patients showing Neu5Gc
positive (M11) and negative individual (M25), treatment by sodium periodate abrogates the 
side chain of sialic acid and reduces the signal and so does blocking
with poly Neu5Gc. C) fluorescent microphotograph of sperm positive and negative for 
Neu5Gc (green fluorescence for anti-Neu5Gc antibody indicated by black
arrow heads, sperm nuclei stained blue with DAPI .
Neu5 Gc Antigen in 
Sperm Samples
Neu5 Gc Antibody in 
Seminal Fluid
Males Undergoing Fertility 
Evaluation 
26% (6/23)* 54% (8/13)†
Male Controls 0% (0/15)* Not measured
*p<0.05
 †Insufficient seminal fluid sample in 10 patients
Table 1. Prevalence of Neu5Gc antigen and Anti-Neu5Gc antibody in semen of male 
subjects undergoing fertility evaluation compared to controls.
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female controls.
Demographics
Male Subjects: Demographics including age (30.5 ± 3.5 years 
vs. 32.2 ± 5.8 years) or BMI (27.3 ± 5.7 kg/m2 vs. 28.7 ± 6.5 kg/m2, 
p-NS) were similar between patients that were positive or negative for 
Neu5Gc antigen on sperm or targeting antibodies within SF (Table 3) 
and controls (31.4 ± 8.5 years and 25.3 ± 4.7 kg/m2).
Female subjects: Age (36.8 ± 6.9 years vs. 33.0 ± 5.7 years), BMI 
(29.1 ± 5.7 kg/m2 vs. 26.5 ± 8.3 kg/m2, p-NS) or primary infertility 
diagnosis (data not shown) was not different between patients that 
were positive or negative for anti-Neu5Gc antibodies in uterine or 
ovarian environments (Table 3).  While controls were significantly 
younger (27.7 ± 2.9 years, p<0.05), BMI was similar (25.2 ±  4.7 kg/
m2) to study subjects. Subjects who were positive for any antibody type 
(IgA, or IgG) within the uterine lavage had a lower gravidity (1.5 ± 1.7 
vs. 2.9 ± 1.8, p<0.05) and parity (0.2 ± 0.4 vs. 1.3 ± 1.5, p<0.05) when 
compared to antibody negative subjects but not to controls (1.4 ± 0.4 
and 1.3 ± 0.4, and 1.3 ± 0.4, p-NS).  No difference was seen in any 
demographic parameter and antibody presence within follicular fluid 
subjects undergoing IVF cycles.  
Diagnostic testing and clinical outcomes 
Semen analysis and saline infusion sonography: Overall, the 
presence of Neu5Gc antigen or anti-Neu5Gc antibodies did not 
correlate with differences in semen quality or the presence of uterine 
pathology.  Specifically, semen volume (3.0 mL vs. 2.7 mL), total sperm 
concentration (55.7 x 106 vs. 42.1 x 106), motility (54.2% vs. 57.9%) and 
morphology (5.5% vs 6.4%), and intrauterine pathology identified on 
saline infusion sonography (18% vs. 38%) were similar regardless of 
Neu5Gc antigen or anti-Neu5Gc antibody status (Table 3). 
Follicular fluid, uterine lavage and IVF outcomes: In those 
undergoing IVF, the total number of retrieved oocytes (10.7 ± 5.5 
vs. 11 ± 5.9, p-NS) and Metaphase II oocytes (8.1 ± 4.2 vs. 8.1 ± 4.0, 
p-NS) were similar regardless of detectable anti-Neu5Gc antibodies 
within follicular fluid of infertility patients.  There were no adverse 
effects of anti-Neu5Gc antibodies on high quality embryos and rates 
of blastulation (data not shown). PR and CPR of these 37 subjects were 
similar in follicular fluid anti-Neu5Gc antibody positive or negative 
patients, respectively (25.0% vs. 23.8%, p-NS) and CPR (18.8% vs. 
23.8%, p-NS). 
Analysis was done on 20 of 37 IVF subjects who had uterine 
lavage with known Neu5Gc antigen and antibody status, The CPR 
per patient was significantly lower in those who were positive for any 
antibody (0% vs. 54.5%, p<0.05) and specifically for IgG antibody (0% 
vs. 50%, p<0.05), though not different in the presence or absence of 
IgA antibody (0% vs. 42.8%, p=0.08). CPR per cycle (fresh and frozen 
combined cycles, n=27) was lower in the presence of any antibody (0% 
vs 50%, p<0.01), IgA antibody (0% vs 31.4%, p<0.01); and IgG antibody 
(0% vs 46.1%, p<0.05) when compared to antibody negative subjects 
(Figures 3 and 4).
Dietary intake and correlation between serum and reproductive 
fluids: No positive correlation was noted between dietary intake 
of red meat, dairy products nor infant formula use and Neu5Gc or 
anti-Neu5Gc antibody status in any reproductive fluid or serum. The 
presence of any serum anti-Neu5Gc antibody positively correlated to 
antibody presence within follicular fluid (r=0.58, p<0.001).  
Discussion
To our knowledge this study is the first to explore the frequency 
of incorporation of non-human xenoglycanNeu5Gc sialic acid and the 
potential role of Neu5Gc and targeting antibody in male and female 
infertility subjects. Our data demonstrate that Neu5Gc and targeting 
antibody are abundantly expressed within both the male and female 
reproductive tracts of infertility subjects. Our preliminary results also 
suggest that the presence of the Neu5Gc xenoantigen or anti-Neu5Gc 
antibodies do not adversely impact sperm parameters or ovarian 
function including oocyte development and embryo quality.  However, 
the presence within the uterine environment may possibly impact 
implantation and pregnancy outcomes.
Uterine Lavage Neu5
 Gc Antigen 
Uterine Lavage 
Neu5 Gc Antibody 
Follicular Fluid
Neu5 Gc Antibody 
Serum 
Neu5 Gc Antibody 
Females Undergoing Fertility 
Evaluation
54% (9/17)* 41% (11/27)† 43% (16/37) 44% (14/32)‡
Female Controls Not measured 0% (0/14)† Not measured Not measured
*Insufficient follicular fluid sample in 10 patients
†p<0.05 
‡ Insufficient follicular fluid sample in 5 patients
Table 2. Prevalence of Neu5Gc antigen and Anti-Neu5Gc antibodies in uterine lavage, folllicular fluid, and serum compared to controls.
 Sperm Neu5Gc p-value
+ -
Subjects n=6 n=17
Age (years) 30.5 ± 3.5 32.2 ± 5.8 NS
BMI (kg/m2) 27.3 ± 5.7 28.7 ± 6.5 NS
Semen Volume (ml) 3 ± 1.6 2.7 ± 1.4 NS
Sperm Conc. (million) 55.7 ± 62.7 42.1 ± 31.1 NS
Total Motility (%) 54.2 ± 20.1 57.9 ± 12.3 NS





Age (years) 36.8 ± 6.9 33 ± 5.7 NS
BMI (kg/m2) 29.1 ± 5.7 26.5 ± 8.3 NS
Gravidity 1.4 ± 1.6 1.5 ± .6 NS
Parity 1 ± 1.7 0.3 ± .5 NS
Pathology on SIS (%) 18 38 NS
Table 3. Comparison of demographics in Neu5Gc antigen positive and negative semen and 
endometrial cells subjects.
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The presence of Neu5Gc antigen or anti-Neu5Gc antibodies is not 
surprising as other investigators have reported the presence of this 
xenoglycan and associated antibodies in both normal and diseased 
human tissues [9,10].  With respect to fertility, it has been suggested 
that antibodies within the uterine environment may impair fertility by 
two potential mechanisms including sperm inactivation and embryo 
rejection or failed implantation secondary to incompatibility between 
the blastocyst and receptive uterus [22].  Our results reveal a lower 
CPR in the presence of anti-Neu5Gc antibodies within the uterine 
environment. Moreover, none of the women positive for anti-Neu5Gc 
IgG antibodies achieved pregnancy even with repeat embryo transfer. 
In light of our study subjects undergoing IVF and the production of 
HQ embryos, it would suggest that implantation may be negatively 
affected in the presence of anti-Neu5Gc antibodies, contributing to 
infertility in these subjects.
The unique human sialic acids biology has brought about a 
situation where a dietary molecule can get incorporated into healthy 
human tissues and become a xeno-auto-antigen. The presence of the 
xeno-auto-antigen Neu5Gc in human reproductive tracts, cells, and 
secretions could contribute to anti-glycan immune related impaired 
fertility (xenosialitis affecting fertility). The presence of a non-self 
glycan (Neu5Gc) at the molecular frontier of the embryo, combined 
with antibodies targeting this molecule is consistent with our observed 
adverse effects on implantation success. 
The fact that we found no consistent correlations between the 
dietary factors and antigen or antibody status is not surprising. The 
accumulation of xenoglycan Neu5Gc is highly variable between 
individuals and between tissues within individuals [9]. Additionally, 
dietary intake over a lifetime is challenging to assess accurately and 
would require very strong associations to detect significant correlations 
with our current intake assessment methodology.  For future studies 
to better address the relationship between dietary load of xenoglycans 
and the biological consequences, extensive resources will need to be 
A           B
Figure 3. Uterine lavage anti-Neu5Gc antibodies by ELISA. A) Measurements of anti-Neu5Gc antibodies by ELISA in uterine lavage of infertility patients. B) Detection of 
Neu5Gc in uterine lavage (shed endometrial cells) by HPLC, standard, positive sample and negative sample
devoted to either collecting dietary intake prospectively over long 
periods of time or developing detailed recall questionnaires specifically 
targeting dietary sources of Neu5Gc. 
Our study demonstrates that Neu5Gc and targeting antibody are 
abundant within the human reproductive tract.  To our knowledge, 
this is the first study to evaluate the role of this xenoglycan and 
targeting antibodies within human fertility. However, there are a 
number of limitations including: 1) small sample size which was not 
powered to detect clinical outcomes; 2) fluids collected were not all 
from same cohort (semen-uterine lavage-follicular fluid-serum); and 
3) the precise localization of Neu5Gc antigen in the uterus could not be 
established beyond its presence on shed epithelial cells recovered from 
the uterine lavage. 
Future studies will focus on elucidating the potential functional 
deficits of sperm bearing Neu5Gc and targeting antibodies and 
 
*p<0.05; †p<0.01.
Figure 4. Pregnancy and clinical pregnancy rates in IVF subjects positive and negative 
for anti-Neu5Gc antibodies (Ab) in uterine lavage.
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evaluating the male and female systems within the same couple in 
order to better understand the role of Neu5Gc and targeting antibodies 
in subfertile or infertile couples. Such investigations will reveal to what 
extent xenosialitis, the contribution of the xenoglycan Neu5Gc to 
heightened or chronic inflammation, also affects human reproduction 
[18]and will point to potential mechanisms involved. 
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